問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol Number201804036MINB
NCT Number(ClinicalTrials.gov Identfier)N/A

2018-08-01 - 2023-07-31

Others

Recruiting2

ICD-10I63.9

Cerebral infarction, unspecified

Investigation of post-stroke neurogenesis using rodent models and patients

  • Trial Applicant

  • Sponsor

    National Taiwan University Hospital

  • Trial scale

    Taiwan Single Center

  • Update

    2025/08/20

Investigators and Locations

Principal Investigator

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator LI-KAI TSAI Division of Neurology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Condition/Disease

post-stroke

Objectives

(1) To use 18F-FLT PET on different types of stroke models, including MCAO, ICH, and SAH, for investigation of the location, timing, pathological correlation, and significance on outcome of cerebral neurogenesis; (2) To enroll different types of stroke patients, including cerebral infarct, ICH, and SAH, and use 18F-FLT PET to study the relationship between neurogenesis and stroke severity as well as post-stroke functional outcome.

Test Drug

18F-FLT

Active Ingredient

3′-deoxy-3′-[18F]-fluorothymidine radio tracer

Dosage Form

injection

Dosage

0.07mCi (2.59MBq)/kg; around 5mCi

Endpoints

(1) To use 18F-FLT PET on different types of stroke models, including MCAO, ICH, and SAH, for investigation of the location, timing, pathological correlation, and significance on outcome of cerebral neurogenesis;
(2) To enroll different types of stroke patients, including cerebral infarct, ICH, and SAH, and use 18F-FLT PET to study the relationship between neurogenesis and stroke severity as well as post-stroke functional outcome.

Inclution Criteria

Inclusion criteria:
This study will include 120 stroke patients and 30 healthy volunteers:
1. Patients with age above 20 years old having stroke, which has been characterized by clinical assessment and head CT or MRI studies.
2. The stroke (ischemic stroke at middle cerebral artery territory; supratentorial ICH; or SAH without delayed cerebral ischemia) at post-stroke 7-14 days.
3. Healthy volunteers with age above 20 years old and without a past history of stroke.
4. Patient and family agree to participate in the study and receive cerebral 18F-FLT PET study.

Exclusion Criteria

Exclusion criteria:
Patients with any of the following conditions will be excluded:
(1) Patients could not receive the PET study because of poor cooperative agitation impeding adequate study, hemodynamic instability, panic mood to PET study or any unstable clinical condition impeding receiving PET study.
(2) Patients with pregnancy or recently having a plan for pregnancy.
(3) Patient or family who does not agree to participate in the study.

The Estimated Number of Participants

  • Taiwan

    150 participants

  • Global

    0 participants